16:48 EST Moleculin Biotech (MBRX) files to sell 2.61M shares of common stock for holders
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBRX:
- Moleculin Biotech Amends Warrants to Boost Nasdaq Compliance
- Buy Rating for Moleculin Biotech: Promising Progress with WP1066 in Pediatric Brain Tumors
- Moleculin Biotech Reports Positive Phase 1 Trial Results
- Moleculin Biotech announces results from Phase 1 trial of WP1066
- Moleculin Biotech Regains Nasdaq Compliance